Hutrope Liophilized 100 IU - Hubio Pharm

Before recombinant biotechnology, HGH was sourced through a labor-intensive process involving the pituitary glands of deceased donors. The risk of transmitting disease eventually forced an end to this method in 1985, following reports of Creutzfeldt-Jakob disease. That same year, Genentech released somatrem, marking the dawn of biosynthetic HGH therapy. Its follow-up, somatropin, provided a molecularly identical version of natural growth hormone. Somatropin remains the trusted option in both clinical endocrinology and non-medical enhancement today.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Hutrope Liophilized 100 IU by Hubio Pharm, consult with your doctor or healthcare professional.